Amgen's strong dividend growth, with a 2.8% yield and consistent hikes since 2011. Read what makes AMGN stock is a worthy ...

POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including ...

A typical corporate fitness challenge teams up colleagues to achieve a specific goal, like accumulating the most steps or ...

The integration of artificial intelligence in healthcare, particularly in radiology, is shifting paradigms in diagnostics.

Today in History for Sept. 30: ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Two new assessments of clinical trials pointed to the need for more investment in Alzheimer's disease treatments. At the 2024 American Geriatrics Society (AGS) scientific meeting, researchers ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

From The American Red Cross - Western North Carolina was hit extremely hard by Helene. Search and rescue operations remain ...

AbbVie Humira, Pfizer/BioNTech COVID-19 shot may not make top 10 pharma drugs in 2024, with Novo Nordisk Ozempic and ...

Multiple sclerosis therapeutic industry is projected to witness a CAGR of 4.7% during the period 2024-2032. This growth can ...

Global Caspofungin Market is valued at approximately USD 462.78 Million in 2022 and is anticipated to grow with a healthy growth rate of more than 1.9% over the forecast period 2023-2030. Read the ...